Literature DB >> 22088276

Amelioration of atherosclerosis by tanshinone IIA in hyperlipidemic rabbits through attenuation of oxidative stress.

Wenying Chen1, Futian Tang, Bailu Xie, Shaorui Chen, Heqing Huang, Peiqing Liu.   

Abstract

Oxidative stress plays a crucial role in atherogenesis, which raises the possibility of using antioxidants to ameliorate atherosclerosis. In the present study, we aim to determine the effects of tanshinone IIA (TSIIA) on atherosclerosis in hyperlipidemic rabbits. After feeding the rabbits on a high-lipid diet for 90 days, they developed severe atherosclerotic lesions both morphologically and biochemically and exhibited significantly elevated serum lipid, malondialdehyde (MDA) and oxidized low density lipoprotein (oxLDL) levels. Oral administration of TSIIA (3-30 mg/kg) greatly inhibited the formation of atherosclerotic lesions. In TSIIA-treated rabbits, there was a marked reduction in serum and aortic lipid peroxide product content, represented by MDA and oxLDL, whereas enhanced activities of superoxide dismutase (SOD) and glutathione peroxidase (GPx) were observed. However, TSIIA had no effect on serum lipid profiles. These results suggest that TSIIA attenuates oxidative stress by decreasing oxLDL production and enhancing activities of SOD and GPx, which might be contributed to the amelioration of atherosclerosis.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22088276     DOI: 10.1016/j.ejphar.2011.10.040

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  23 in total

1.  Cryptotanshinone, an orally bioactive herbal compound from Danshen, attenuates atherosclerosis in apolipoprotein E-deficient mice: role of lectin-like oxidized LDL receptor-1 (LOX-1).

Authors:  Zhiping Liu; Suowen Xu; Xiaoyang Huang; Jiaojiao Wang; Si Gao; Hong Li; Changhua Zhou; Jiantao Ye; Shaorui Chen; Zheng-Gen Jin; Peiqing Liu
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

2.  Tanshinone IIA Attenuates Atherosclerosis in Apolipoprotein E Knockout Mice Infected with Porphyromonas gingivalis.

Authors:  Yan Xuan; Yue Gao; Hao Huang; Xiaoxuan Wang; Yu Cai; Qing Xian Luan
Journal:  Inflammation       Date:  2017-10       Impact factor: 4.092

3.  Insights into the antiatherogenic molecular mechanisms of andrographolide against Porphyromonas gingivalis-induced atherosclerosis in rabbits.

Authors:  Rami Al Batran; Fouad Al-Bayaty; Mazen M Jamil Al-Obaidi; Amer Ashrafi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-08-30       Impact factor: 3.000

Review 4.  Salvia miltiorrhizaBurge (Danshen): a golden herbal medicine in cardiovascular therapeutics.

Authors:  Zhuo-Ming Li; Suo-Wen Xu; Pei-Qing Liu
Journal:  Acta Pharmacol Sin       Date:  2018-04-26       Impact factor: 6.150

5.  Tanshinone IIA suppresses cholesterol accumulation in human macrophages: role of heme oxygenase-1.

Authors:  Zhiping Liu; Jiaojiao Wang; Erwen Huang; Si Gao; Hong Li; Jing Lu; Kunming Tian; Peter J Little; Xiaoyan Shen; Suowen Xu; Peiqing Liu
Journal:  J Lipid Res       Date:  2013-12-03       Impact factor: 5.922

Review 6.  Chinese Herbal Medicines and Active Metabolites: Potential Antioxidant Treatments for Atherosclerosis.

Authors:  Luxia Song; Jie Zhang; Runmin Lai; Qiuyi Li; Jianqing Ju; Hao Xu
Journal:  Front Pharmacol       Date:  2021-05-13       Impact factor: 5.810

7.  Tanshinone IIA attenuates interleukin-17A-induced systemic sclerosis patient-derived dermal vascular smooth muscle cell activation via inhibition of the extracellular signal-regulated kinase signaling pathway.

Authors:  Mengguo Liu; Ji Yang; Ming Li
Journal:  Clinics (Sao Paulo)       Date:  2015-04       Impact factor: 2.365

Review 8.  Anti-Inflammatory and Immunomodulatory Mechanism of Tanshinone IIA for Atherosclerosis.

Authors:  Zhuo Chen; Hao Xu
Journal:  Evid Based Complement Alternat Med       Date:  2014-12-02       Impact factor: 2.629

9.  Evaluation of the Effects of Vaccinium arctostaphylos L. Fruit Extract on Serum Lipids and hs-CRP Levels and Oxidative Stress in Adult Patients with Hyperlipidemia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

Authors:  Rasool Soltani; Mustafa Hakimi; Sedigheh Asgary; Syed Mustafa Ghanadian; Mahtab Keshvari; Nizal Sarrafzadegan
Journal:  Evid Based Complement Alternat Med       Date:  2014-01-23       Impact factor: 2.629

Review 10.  Natural Formulations: Novel Viewpoint for Scleroderma Adjunct Treatment.

Authors:  Shirin Assar; Hosna Khazaei; Maryam Naseri; Fardous El-Senduny; Saeideh Momtaz; Mohammad Hosein Farzaei; Javier Echeverría
Journal:  J Immunol Res       Date:  2021-06-24       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.